IL-23+ macrophages expanded anti-tumorigenic Th17 cells that had a distinct phenotype known as Th1-like Th17 cells and promoted tumor-specific immune responses by secreting IFN-γ, CXCL9 and CXCL10 [86,87]. This evidence concerns the gene CXCL10 and neoplasm.